陈为一, 李小龙, 齐岳亮, et al. Effect ofPTTG1in the invasion of glioma cells[J]. China Oncology, 2014, 24(5): 329-332. DOI: 10.3969/j.issn.1007-3969.2014.05.002.
Background and purpose: Numerous researches indicated that the expression of pituitary tumor transforming gene1 (PTTG1) was correlated with the severity of glioma tumors. However the specific mechanism of PTTG1 is not clear in glioma. In this study
we explored the role and significance of PTTG1 in the invasion of glioma cells. Methods: Western blot was used to detect the expression of PTTG1 protein in various glioma cell lines. siRNA plasmid was used to transfect U87 cells. Western blot was used to analyze the expression of PTTG1 protein in transfected U87 cells. Matrigel invasion assay was used to detect the invasive ability in the cells being transfected in vitro. Western blot was used to analyze epithelial growth factor (EGF) induced protein phosphorylation of ARK5 and Akt in the cells being transfected PTTG1 plasmid (siPTTG1/U87) and scrambled siRNA (Scr/U87). Results: The expression of PTTG1 protein was higher in all glioma cell lines. After transfection
the invasion of siPTTG1/U87 was obviously decreased after 5 min with EGF stimulation than the Scr/U87
the phosphorylation of ARK5 and Akt was significantly enhanced. However
whether or not the existence of EGF
the phosphorylation of ARK5 and Akt had no differences in siPTTG1/U87. Conclusion: In glioma cells
PTTG1 protein is high expressed and maybe have an important function in glioma cells invasion through Akt-ARK5 signaling pathway.
Nir1 promotes invasion of glioma cells by binding to chemokine (C–C motif) ligand 18
Retrospective study on MGMT methylation status and its clinical significance in gliomas
WTAP promotes proliferation and aerobic glycolysis via regulating m6A modification of BMI1 mRNA
Screening recurrent glioblastoma-related genes and analyzing their gene expressions in association with clinicopathological parameters and prognosis
Effect ofCHKAgene silencing on biological behavior of glioma cell and its mechanism
Related Author
田红艳
陈萍萍
Tian XUE
Heng CHANG
Jing ZHANG
Liqing JIA
Xiaoyan ZHOU
Xiaoli ZHU
Related Institution
Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Fudan University Cancer Institute
Department of Neurosurgery, Wu’an First People’s Hospital
Department of Neurosurgery, the First Affiliated Hospital of Nanyang Medical College
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University